HRES 1207 is a House Resolution that expresses support for protecting Americans from the perceived harmful effects of private equity firms, particularly in essential sectors like housing, child care, healthcare, energy, and nursing homes. The resolution recognizes the need for a comprehensive plan to address these issues. This plan includes raising staffing, safety, and pay standards in care industries, ending taxpayer subsidies for institutional investors buying homes, and guaranteeing legal counsel for tenants. It also calls for greater transparency of private equity ownership, strengthened antitrust reviews, and support for alternative, non-private equity providers in these critical sectors.
This House Resolution recognizes the vital roles and contributions of care workers in the United States, including those in childcare and home care, and expresses support for designating April 2026 as "Care Worker Recognition Month." It aims to acknowledge the importance of these professionals who support children, older adults, and people with disabilities, and their impact on families and the economy.
The OPTIONS Act establishes a new type of employer-sponsored benefit arrangement called a Qualified Benefit Options Plan (QBOP), affecting employers and their employees. Under a QBOP, employees can choose how their employer's contributions are allocated among various pre-tax qualified benefits, such as contributions to retirement plans, health savings accounts, or educational assistance programs. A key distinction is that employees cannot opt to receive cash or other taxable benefits instead of these qualified benefits. Employer contributions made through a QBOP are excluded from an employee's taxable income, offering a tax-advantaged way for employers to provide flexible benefit options. The bill includes rules to ensure benefits are not disproportionately skewed towards highly compensated employees and applies to taxable years beginning after December 31, 2025.
This bill, HR 8391, proposes to expand the types of services covered under the Medicare and Medicaid programs. It directly affects Medicare beneficiaries and Medicaid recipients by requiring coverage for certain food and nutrition services. Under Medicare, these services would be covered, with Medicare paying 80% of the actual charge. For Medicaid, these services would also be covered and become a mandatory benefit that states must provide. The Secretary of Health and Human Services will specify the exact requirements for these services, and the changes would take effect 180 days after the bill's enactment.
The Educational Equity Challenge Grant Act of 2026 establishes a federal grant program to provide funding to local and state educational agencies, non-profit partnerships, and other eligible entities. These grants aim to address students' academic, social-emotional, mental, behavioral, and physical health needs, especially those exacerbated by the COVID-19 pandemic. Funds will support either evidence-based activities or innovative, educator-initiated proposals, with specific allocations for rural areas, low-income student populations, and tribal schools. Priority will be given to applicants serving high-need students, including those from low-income families, students of color, and students with disabilities, to promote equitable educational outcomes. Grant recipients must report on how funds were used and their effect on student learning and well-being.
The Every Dollar Counts Act of 2026 requires health insurance plans and issuers to count money spent by individuals on prescription drugs purchased directly, without applying their insurance benefits, towards their annual deductible and out-of-pocket maximums. This means that if an individual pays cash for a drug or uses a discount card instead of their insurance benefits, those expenditures will still contribute to reaching their yearly healthcare spending limits. This change directly affects individuals enrolled in group or individual health insurance coverage. The new rules will take effect for plan years beginning on or after January 1, 2027.
This bill, the "Stop Deadly Denials Act of 2026," aims to significantly restrict prior authorization requirements for Medicare beneficiaries. It prohibits Medicare Advantage plans from imposing prior authorization for most medical services and items starting January 1, 2027, with non-compliant plans facing potential sanctions. For traditional Medicare, the bill blocks a specific prior authorization pilot program and limits future models from implementing prior authorization if they use artificial intelligence for denials without individual physician review or do not use Medicare administrative contractors for processing. Additionally, it requires public notice and comment for all future Medicare innovation models.
The CLEAR LABELS Act aims to increase transparency in the drug supply chain by requiring more detailed information on pharmaceutical labels. It mandates that finished drug products' labels, or linked electronic portals, include the name, location, and unique identifier of the manufacturer, packer, or distributor. Additionally, labels must identify the original manufacturer of both the finished drug product and each active pharmaceutical ingredient, with this information also available in paper form upon request. The bill further exempts finished drug products from standard customs country-of-origin marking if they comply with these new labeling requirements.
The "Workforce Recovery and Resilience Act" amends current law to address the workforce and economic impacts of substance use disorders. It requires the Department of Labor to provide states and local areas with information on effective practices for tackling these impacts, including how to access relevant funding. The bill also expands the use of national dislocated worker grants to fund employment and training activities related to substance use disorder prevention and treatment in areas heavily affected by addiction. Eligible individuals for these specific grants include dislocated workers, the long-term unemployed, those impacted by widespread substance use, and individuals in healthcare professions focused on substance use treatment.
This bill, the Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026, extends an existing federal program. It reauthorizes the Public Health and Bio-Preparedness Workforce Loan Repayment Program, which provides loan repayment assistance to professionals in public health and bio-preparedness fields. The key provision updates the program's funding authorization period. Specifically, it changes the authorization from fiscal years 2023 through 2025 to fiscal years 2027 through 2031, allowing the program to continue supporting this workforce.
